Gabriella Douglass
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Unknown Researcher
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Gabriella Douglass's research focuses on the roles of clinical pharmacists in various healthcare settings and the development of programs to improve patient outcomes. She has investigated the adaptation of pharmacist-led programs for long-acting injectable antiretroviral therapy to increase its use in an Ending the HIV Epidemic jurisdiction. Douglass has also examined provider support for pharmacist lactation consultant training to promote long-term breastfeeding and comprehensive medication management for mother-infant dyads.
Her work includes surveys of healthcare providers regarding the roles of clinical pharmacists in primary care, comparing Federally Qualified Health Centers with Accountable Care Organizations. Douglass has collaborated with researchers from Harding University and the University of Arkansas for Medical Sciences on these studies. Her scholarship metrics include an h-index of 1 and five total publications.
Metrics
- h-index: 1
- Publications: 5
- Citations: 6
Selected Publications
-
P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction (2026)
-
Aspire to be smoke-free pilot study: A prevention educationaloutreach serving preschool children in rural Arkansas (2020)
Collaboration Network
Top Collaborators
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
Similar Researchers
Based on overlapping research topics